Quantcast

April 26 Webinar: Experts Discuss What Steps Can Be Taken to Combat the Growing Use of Consumer Copay Coupons

April 23, 2012

Experts in the pharmaceutical industry will detail strategies that health plans can use to combat copay coupons in this April 26 webinar sponsored by Atlantic Information Services.

Washington, DC (PRWEB) April 23, 2012

Atlantic Information Services, Inc., publisher of Drug Benefit News and Specialty Pharmacy News, is pleased to announce its April 26 webinar, Health Plan Strategies to Combat Consumer Drug Copay Coupons. See webinar details at http://aishealth.com/marketplace/c2p15_042612.

As payers and consumers reap the benefits of the generic drug wave, pharmaceutical manufacturers are desperately trying to hold onto market share and maintain brand loyalty through the promotion of controversial copay coupons for their brand-name products. Many PBMs and health plan pharmacy directors argue that such promotions undermine formulary efforts by steering patients toward costly brand-name drugs when less expensive, equally effective therapeutic options exist. In a study released last November, the Pharmaceutical Care Management Association contended that copay coupons could even raise drug costs by $32 billion over a 10-year period.

On April 26, Brent Eberle, R.Ph., from PBM Navitus Health Solutions, LLC, and Rob Noel, from Pharmaceutical Strategies Group, LLC, will discuss what steps they are taking to combat the growing use of consumer copay coupons for private-sector clients. Webinar participants will learn:

  • The details of what a consumer copay coupon is and which drug products are likely candidates for couponing.
  • How consumer copay coupons are likely to be influencing overall drug spend.
  • How to evaluate formulary and utilization management strategies to ensure that patients and physicians have access to clinically appropriate therapies.
  • How the removal of high-cost, nonpreferred drugs linked to consumer copay coupons from formulary can be done in a way to reduce any negative impact to patients.
  • The changing strategies of pharmaceutical manufacturers as they compete to maintain market share of blockbuster drugs.

Visit http://aishealth.com/marketplace/c2p15_042612 for more details and registration information.

About AIS

AIS develops highly targeted news, data and strategies for managers in hospitals, health plans, medical group practices, pharmaceutical companies and other health care organizations. Learn more at http://www.AISHealth.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/4/prweb9422857.htm


Source: prweb



comments powered by Disqus